Search for: All records

We present a full-spectrum machine learning framework for refractive index sensing using simulated absorption spectra from meta-grating structures composed of titanium or silicon nanorods under TE and TM polarizations. Linear regression was applied to 80 principal components extracted from each spectrum, and model performance was assessed using five-fold cross-validation, simulating real-world biosensing scenarios where unknown patient samples are predicted based on standard calibration data. Titanium-based structures, dominated by broadband intensity changes, yielded the lowest mean squared errors and the highest accuracy improvements—up to an 8128-fold reduction compared to the best single-feature model. In contrast, silicon-based structures, governed by narrow resonances, showed more modest gains due to spectral nonlinearity that limits the effectiveness of global linear models. We also show that even the best single-wavelength predictor is identified through data-driven analysis, not visual selection, highlighting the value of automated feature preselection. These findings demonstrate that spectral shape plays a key role in modeling performance and that full-spectrum linear approaches are especially effective for intensity-modulated index sensors. 

In this work, a miniaturized, automated, and cost-effective ELISA device is designed and implemented, without the utilization of conventional techniques such as pipetting or microfluidic valve technologies. The device has dimensions of 24 cm × 19 cm × 14 cm and weighs <3 kg. The total hardware cost of the device is estimated to be approximately $1200, which can be further reduced through optimization during scale-up production. Three-dimensional printed disposable parts, including the reagent reservoir disk and the microfluidic connector, have also been developed. IL-6 is used as a model system to demonstrate how the device provides an ELISA measurement. The cost per test is estimated to be <$10. The compactness, automated operation, along with the cost-effectiveness of this ELISA device, makes it suitable for point-of-care applications in resource-limited regions.